Daily Briefing · 2026-11-05

Micron, Sandisk, Nvidia, and Apple all declined as investors reassessed the outlook for AI monetization and data-center spending following the Democrats' midterm election victory. A research firm declared what it called the end of the AI trade as we know it, pointing to a shift in Asian tech stocks from near-term value plays toward longer-term speculative AI positioning. Tech industry leaders told the Financial Times that growing public backlash against AI development now threatens trillion-dollar data-center expansion plans. Analysts said the real test for the AI infrastructure buildout will come in 2028, warning that midterm-driven policy uncertainty could affect funding for the sector. Anthropic's planned IPO faces headwinds from elevated AI infrastructure costs and ongoing market turbulence, MarketWatch reported. MarketWatch also noted that some of 2026's most successful stock trades are unraveling amid the sharp market rotation, a reversal that could prove lasting. Robot maker Agility began trading following its SPAC merger, though MarketWatch flagged the company's steep operating losses as a red flag for its path to profitability. European equities approached record highs, as investors bet the Democratic midterm sweep would constrain restrictive fiscal and trade policy, the Financial Times reported. A strategist told MarketWatch that a prolonged war in Iran remains an unpriced black swan risk for markets, with potential for significant losses across asset classes if the conflict escalates. Analysts added that continued oil price increases could force central banks to raise interest rates significantly higher, even if the Iran conflict is resolved soon. NPR reported that a Democratic-controlled Congress has limited direct tools to lower fuel prices, though shifts in Iran policy could ease some supply disruptions. A strategist drew a comparison to the nineteen-eighties, arguing that bipartisan cooperation between a Republican president and a Democratic House Speaker, combined with Fed inflation-fighting measures, could drive a major stock rally. Revolution Medicines' newly launched pancreatic cancer treatment exceeded sales expectations in its first weeks on the market, positioning it as a potential blockbuster, MarketWatch reported. Toyota shares rallied despite the company lowering its annual sales guidance, an unusually rare market reaction MarketWatch said is typically reserved for firms with offsetting positive catalysts. MarketWatch reported that first-time home buyers paying entirely in cash rose to a record ten percent, as wealthier buyers increasingly bypass financing in an affordability-challenged housing market. The wealthiest ten percent of Americans saw their median net worth climb by eight hundred thousand dollars over three years, significantly outpacing wealth gains for other income groups, MarketWatch reported.